Innovation for people,

research for the future


Nóos is an Italian company with over 20 years’ experience, which combines science and advanced technology to offer solutions and improve the health and well-being of individuals. Our passion for innovation leads us to research and develop new products that can enhance the quality of everyday life.

Scientific research, clinical studies, the necessary pharmaceutical rigour and a particular focus on family care are the unique qualities that allow us to achieve ever more ambitious goals, obtaining new patents and creating new formulas: this is the strength that makes us stand out from the crowd.

We regard science as a means of fulfilling the needs of families, both parents and children, and supporting current and future generations.


Nóos means innovation, research and quality.
The day-to-day wellbeing and future of individuals is at the heart of our corporate strategy.


For over 20 years we have been designing, testing and developing high-quality food supplements and medical devices to meet the needs of families. Thanks to the enormous expertise gained by our founders through years in the pharmaceutical industry, we have successfully brought scientifically rigorous values and quality to our products.


Nóos is founded
Nóos is founded in 1999, fruit of the founders' long experience in the pharmaceutical industry.
The company brings to its products, supplements and medical devices the same scientific approach and rigorous quality as that used in pharmaceuticals. Today, the medical community continues to recognise and appreciate these values, showing confidence and great interest in our therapeutic products, which are mainly geared to supporting paediatrics, neonatology, otolaryngology, gastroenterology, allergology and general practice.
Nóos is founded
Nóos signs an exclusive concession agreement with Biogaia AB in Italy for the probiotic Lactobacillus reuteri DSM 17938, launched on the Italian market under the brand name Reuterin®, as a result of ongoing commitment to clinical development and scientific research.
Linfovir® plus
Nóos registers an international patent and launches a line of respiratory products on the Italian market based on its own research. The patented combination resveratrol+carboxymethyl betaglucan will launch on the Italian market as a medical device under the brand name LinfoVir plus®.
Linfovir® plus
Elite Project
Nóos joins the Elite project, an innovative platform created by the Italian Stock Exchange that offers dedicated services for ambitious companies to benchmark themselves against the best international models and practices. An opportunity to connect with a community of excellence in order to foster and benefit from all available business matching opportunities.
Elite Project
After several years of clinical research, Nóos obtains an important patent and launches Pentabiocel® in Italy. Pentabiocel® is a food supplement based on an innovative patented mixture of 5 probiotics.
ISO 9001 certification
The company obtains ISO 9001 certification. An ISO 9001-compliant management system is a cornerstone for corporate improvement and a valuable aid in planning strategies and objectives.
ISO 9001 certification

The contents inside the restricted area are exclusively dedicated to healthcare professionals.

By accepting to view these pages you declare that you are a healthcare professional.

Do you wish to continue?